EGF and ovarian cancer: Those authors showed that the gel reduced the invasion of ovarian cancer cells in an immunocompromised mouse model, specifically through the inhibition of signals initiated by epidermal growth factor and the reduced expression of proteins linked to metastasis (such as Rac1 protein).